Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest medullary thyroid cancer Stories

2013-11-13 08:29:25

SOUTH SAN FRANCISCO, Calif., Nov. 13, 2013 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) today announced that it presented new data suggesting the ability of its Afirma Gene Expression Classifier (GEC) to accurately identify medullary thyroid cancer (MTC) among thyroid nodule fine needle aspiration (FNA) samples that are indeterminate and sub-classified as Hurthle cell neoplasms by cytopathology. The findings were presented in a poster session at the American Society of...

Link Suggested Between Nervous System And Cancer
2013-10-15 12:24:53

UT Southwestern Medical Center A specific protein once thought to exist only in the brain may play a crucial role in a deadly form of thyroid cancer, as well as other cancers, and provide a fresh target for researchers seeking ways to stop its progression, UT Southwestern Medical Center researchers report today in Cancer Cell. The scientists found that over-activation of a certain protein in hormone-secreting cells helps fuel medullary thyroid cancer cells in mice as well as in human...

2013-10-09 11:47:30

Findings from the first study to show a specific function of the immune system in the proliferation of thyroid cancer may ultimately change the course of treatment Researchers at the National Institutes of Health (NIH), Bethesda, MD, have taken the first steps to determine if a protein, called Programmed Death Ligand 1 (PD-L1), can help to predict which thyroid cancer patients will most likely have a recurrence of the disease. Study findings were presented today at the 2013 Clinical...

2013-02-04 08:26:36

BURLINGTON, Mass., Feb. 4, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through 2021, the treatment landscape for thyroid carcinoma will change dramatically in the United States and Europe due to the expected approval of several new therapies. In addition to Exelixis's Cometriq (cabozantinib) for advanced medullary thyroid carcinomas (MTC)--which was approved in the U.S. late last...

2012-08-20 00:20:05

Tokyo, Aug 20, 2012 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has received orphan drug designation from Japan's Ministry of Labour, Health and Welfare for its multikinase inhibitor lenvatinib mesylate ("lenvatinib") for the treatment of thyroid cancer, the drug's prospective indication.Lenvatinib, discovered and being developed in-house, is an anti-angiogenic agent with a unique inhibitory profile against the receptor tyrosine kinase family of kinases. It is a potent...

2012-03-30 07:42:16

New study challenges assumption that thyroidectomy is a low-risk operation for older patients Elderly patients who undergo thyroid surgery are at a much higher risk than their younger counterparts for serious cardiac, pulmonary and infectious complications, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). The study findings challenge long-held beliefs that thyroidectomy carries the same risk level of...

2012-01-22 12:00:00

REYKJAVIK, Iceland, January 22, 2012 /PRNewswire/ -- Scientists at deCODE Genetics and academic collaborators from Iceland, the USA, The Netherlands and Spaintoday report the discovery of variants in the human genome that associate with levels of thyroid stimulating hormone and risk of thyroid cancer.The paper 'Discovery of common variants associated with low TSH levels and thyroid cancer risk' is published today in the online edition of Nature Genetics. Using data...

2011-12-20 22:42:34

Procedure may reduce recurrence rates, lower tumor marker levels Papillary thyroid cancer accounts for the majority of all thyroid malignancies, which primarily impact women. A new study indicates that routinely removing lymph nodes in the neck in these cancer patients may help prevent the disease from coming back. When thyroid cancer metastasizes, lymph nodes in the neck may be affected, but these lymph-node tumors can be tiny and may not be detected by ultrasounds done before surgery...

2011-11-10 09:00:00

SARASOTA, Fla., Nov. 10, 2011 /PRNewswire/ -- Amy Murray, a 35-year old mother of two, had a sore throat for weeks. When she begun to have trouble swallowing, she thought she might have strep throat, and went to see her doctor. He found a lump in her neck, and after several medical tests, Murray was diagnosed with papillary thyroid cancer. According to TMD Limited, a medical research company, Murray's research and ultimate decision to seek treatment outside of the US is typical of more...

2011-06-06 14:59:19

A mutant gene long thought to accelerate tumor growth in thyroid cancer patients actually inhibits the spread of malignant cells, showing promise for novel cancer therapies, a Mayo Clinic study has found. The findings will be presented by Mayo Clinic researcher Honey Reddi, Ph.D., at the Endocrine Society meeting in Boston. Dr. Reddi's discovery could have widespread implications in cancer research and endocrinology. It could help oncologists sharpen the diagnosis of specific types of thyroid...